Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
The Technology Select Sector SPDR® Fund
XLK
4
Invesco Solar ETF
TAN
5
VanEck Oil Services ETF
OIH
US Stock MarketDetailed Quotes
Keros Therapeutics (KROS)
- 10.590
- -1.400-11.68%
Trading May 14 10:58 ET
209.55MMarket Cap4.60P/E (TTM)
11.810High10.520Low176.00KVolume11.740Open11.990Prev Close1.94MTurnover0.92%Turnover Ratio4.60P/E (Static)19.79MShares22.55052wk High0.69P/B203.20MFloat Cap10.41552wk Low--Dividend TTM19.19MShs Float88.800Historical High--Div Yield TTM10.76%Range %9.120Historical Low11.002Avg Price1Lot Size
KROS Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
KROS Orderflow
Unit: --
KROS Orderflow Trend
IntradayDayWeekMonth
No Data
Keros Therapeutics (KROS) News
Keros Therapeutics Q1 EPS $(1.21) Misses $(1.02) Estimate, Sales $367.000K Miss $583.333K Estimate
Keros Therapeutics | 10-Q: Quarterly report
Keros Therapeutics | 8-K: Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
Express News | Keros Therapeutics Q1 Net Income USD -23.708 Million
KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
KROS Stock: What to Know About Rinvatercept in DMD
Keros Therapeutics (KROS) Stock Forum
$Keros Therapeutics (KROS.US)$
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
Monday, 9th March at 8:00 am
LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunction...
Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference
Monday, 9th March at 8:00 am
LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros" or the "Company") (NASDAQ: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunction...
2
$Scilex Holding (SCLX.US)$ $Western Copper & Gold (WRN.US)$ $The Lovesac (LOVE.US)$ $Cumulus Media (CMLS.US)$ $MAX AUTO INDUSTRY -3X INVERSE LEVERAGED ETN (CARD.US)$ $Keros Therapeutics (KROS.US)$ $Avalon GloboCare (ALBT.US)$ $LogicMark (LGMK.US)$ $Genfit (GNFT.US)$ $Hydrofarm (HYFM.US)$ $Pasithea Therapeutics (KTTA.US)$ $SUNation Energy (SUNE.US)$ $ReShape Lifesciences (RSLS.US)$ $Sharps Technology (STSS.US)$ $Wheeler Real Estate Investment Trust (WHLR.US)$
7
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)